Stock Events

Alnylam Pharmaceuticals (DUL.F) Q2 2023 Earnings

DUL.F +1.11%
4MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-2.7
-2.22
-1.75
-1.27

Details

Expected EPS
-1.6238343000000002
Actual EPS
-1.270038
Surprise EPS
0.35
Surprise Percent
+21.79%

Description

Alnylam Pharmaceuticals (DUL.F) has reported earnings of -1.270038 per share for Q2 2023.

0 Comments

Share your thoughts